bf/NASDAQ:VRTX_icon.jpeg

COM:VRTX

Vertex Pharmaceuticals Incorporated

  • Stock

Last Close

501.72

12/11 19:29

Market Cap

126.86B

Beta: -

Volume Today

430.58K

Avg: -

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients ...Show More

peer of

invested in

competitor of